GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Days Sales Outstanding

Covalon Technologies (TSXV:COV) Days Sales Outstanding : 50.30 (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Covalon Technologies Days Sales Outstanding?

Covalon Technologies's average Accounts Receivable for the three months ended in Dec. 2024 was C$4.50 Mil. Covalon Technologies's Revenue for the three months ended in Dec. 2024 was C$8.17 Mil. Hence, Covalon Technologies's Days Sales Outstanding for the three months ended in Dec. 2024 was 50.30.

The historical rank and industry rank for Covalon Technologies's Days Sales Outstanding or its related term are showing as below:

TSXV:COV' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.48   Med: 70.69   Max: 111.92
Current: 51.25

During the past 13 years, Covalon Technologies's highest Days Sales Outstanding was 111.92. The lowest was 22.48. And the median was 70.69.

TSXV:COV's Days Sales Outstanding is ranked better than
67.85% of 843 companies
in the Biotechnology industry
Industry Median: 69.63 vs TSXV:COV: 51.25

Covalon Technologies's Days Sales Outstanding declined from Dec. 2023 (94.25) to Dec. 2024 (50.30).


Covalon Technologies Days Sales Outstanding Historical Data

The historical data trend for Covalon Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Days Sales Outstanding Chart

Covalon Technologies Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 94.14 90.77 111.92 74.76 57.42

Covalon Technologies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.25 50.20 58.70 50.04 50.30

Competitive Comparison of Covalon Technologies's Days Sales Outstanding

For the Biotechnology subindustry, Covalon Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Days Sales Outstanding falls into.


;
;

Covalon Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Covalon Technologies's Days Sales Outstanding for the fiscal year that ended in Sep. 2024 is calculated as

Days Sales Outstanding (A: Sep. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Sep. 2024 )) / count ) / Revenue (A: Sep. 2024 )*Days in Period
=( (6.162 + 3.645) / 2 ) / 31.169*365
=4.9035 / 31.169*365
=57.42

Covalon Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding (Q: Dec. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2024 ) + Accounts Receivable (A: Dec. 2024 )) / count ) / Revenue (A: Dec. 2024 )*Days in Period
=( (3.645 + 5.357) / 2 ) / 8.166*365 / 4
=4.501 / 8.166*365 / 4
=50.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Covalon Technologies  (TSXV:COV) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Covalon Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes and save lives in the areas of infection management, wound care, and surgical procedures. The company generates its revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products are CovaClear, IV IV Clear, SurgiClear, and VALGuard.
Executives
Amir Boloor Director
Valerio Ditizio Director or Senior Officer of 10% Security Holder, Senior Officer

Covalon Technologies Headlines

No Headlines